Works by Iacovelli, Roberto

Results: 97
    1

    Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes?

    Published in:
    Cancers, 2025, v. 17, n. 13, p. 2189, doi. 10.3390/cancers17132189
    By:
    • Bizzarri, Francesco Pio;
    • Campetella, Marco;
    • Russo, Pierluigi;
    • Palermo, Giuseppe;
    • Moosavi, Seyed Koosha;
    • Rossi, Francesco;
    • D'Amico, Lorenzo;
    • Cretì, Antonio;
    • Gavi, Filippo;
    • Panio, Enrico;
    • Presutti, Simona;
    • Bellavia, Fabrizio;
    • Ragonese, Mauro;
    • Ciccarese, Chiara;
    • Iacovelli, Roberto;
    • Sighinolfi, Maria Chiara;
    • Racioppi, Marco;
    • Sacco, Emilio;
    • Rocco, Bernardo
    Publication type:
    Article
    2
    3
    4
    5

    Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
    By:
    • Rebuzzi, Sara Elena;
    • Cerbone, Luigi;
    • Signori, Alessio;
    • Santoni, Matteo;
    • Murianni, Veronica;
    • De Giorgi, Ugo;
    • Procopio, Giuseppe;
    • Porta, Camillo;
    • Milella, Michele;
    • Basso, Umberto;
    • Massari, Francesco;
    • Maruzzo, Marco;
    • Iacovelli, Roberto;
    • Battelli, Nicola;
    • Carmisciano, Luca;
    • Banna, Giuseppe Luigi;
    • Buti, Sebastiano;
    • Fornarini, Giuseppe
    Publication type:
    Article
    6

    External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.

    Published in:
    Clinical & Experimental Metastasis, 2024, v. 41, n. 2, p. 117, doi. 10.1007/s10585-024-10266-6
    By:
    • Maffezzoli, Michele;
    • Santoni, Matteo;
    • Mazzaschi, Giulia;
    • Rodella, Sara;
    • Lai, Eleonora;
    • Maruzzo, Marco;
    • Basso, Umberto;
    • Bimbatti, Davide;
    • Iacovelli, Roberto;
    • Anghelone, Annunziato;
    • Fiala, Ondřej;
    • Rebuzzi, Sara Elena;
    • Fornarini, Giuseppe;
    • Lolli, Cristian;
    • Massari, Francesco;
    • Rosellini, Matteo;
    • Mollica, Veronica;
    • Nasso, Cecilia;
    • Acunzo, Alessandro;
    • Silini, Enrico Maria
    Publication type:
    Article
    7

    FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma.

    Published in:
    Oncologist, 2014, v. 19, n. 8, p. 845, doi. 10.1634/theoncologist.2014-0106
    By:
    • Pietrantonio, Filippo;
    • Maggi, Claudia;
    • Fanetti, Giuseppe;
    • Iacovelli, Roberto;
    • Di Bartolomeo, Maria;
    • Ricchini, Francesca;
    • Deraco, Marcello;
    • Perrone, Federica;
    • Baratti, Dario;
    • Kusamura, Shigeki;
    • Tamborini, Elena;
    • Castano, Alessandra;
    • Consonni, Paola Valentina;
    • Bossi, Ilaria;
    • Gavazzi, Cecilia;
    • Milione, Massimo;
    • Pelosi, Giuseppe;
    • Braud, Filippo
    Publication type:
    Article
    8
    9
    10

    DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group.

    Published in:
    Cancer Cytopathology, 2023, v. 131, n. 3, p. 158, doi. 10.1002/cncy.22657
    By:
    • Pierconti, Francesco;
    • Rossi, Esther Diana;
    • Cenci, Tonia;
    • Carlino, Angela;
    • Fiorentino, Vincenzo;
    • Totaro, Angelo;
    • Sacco, Emilio;
    • Palermo, Giuseppe;
    • Iacovelli, Roberto;
    • Larocca, Luigi Maria;
    • Bassi, Pier Francesco;
    • Martini, Maurizio
    Publication type:
    Article
    11

    Biomarkers of response to advanced prostate cancer therapy.

    Published in:
    Expert Review of Molecular Diagnostics, 2020, v. 20, n. 2, p. 195, doi. 10.1080/14737159.2020.1707669
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Schinzari, Giovanni;
    • Rossi, Ernesto;
    • Maiorano, Brigida Anna;
    • Astore, Serena;
    • D'Angelo, Tatiana;
    • Cannella, Antonella;
    • Pirozzoli, Celeste;
    • Teberino, Maria Anna;
    • Pierconti, Francesco;
    • Martini, Maurizio;
    • Tortora, Giampaolo
    Publication type:
    Article
    12

    The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.

    Published in:
    Targeted Oncology, 2025, v. 20, n. 3, p. 405, doi. 10.1007/s11523-025-01141-9
    By:
    • Pinterpe, Giada;
    • Migliaccio, Fortuna;
    • Ciccarese, Chiara;
    • Pedone, Romina Rose;
    • Belletto, Rachele;
    • Russo, Pierluigi;
    • Totaro, Angelo;
    • Tagliaferri, Luca;
    • Sighinolfi, Chiara;
    • Formisano, Luigi;
    • Berardi, Rossana;
    • Rocco, Bernardo;
    • Tortora, Giampaolo;
    • Iacovelli, Roberto
    Publication type:
    Article
    13

    Defining the Position of [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials: [<sup>177</sup>Lu]Lu-PSMA RLT in mCRPC: A Meta-analysis of Clinical Trials: C. Ciccarese et al

    Published in:
    Targeted Oncology, 2025, v. 20, n. 1, p. 103, doi. 10.1007/s11523-024-01117-1
    By:
    • Ciccarese, Chiara;
    • Bauckneht, Matteo;
    • Zagaria, Luca;
    • Fornarini, Giuseppe;
    • Beccia, Viria;
    • Lanfranchi, Francesco;
    • Perotti, Germano;
    • Pinterpe, Giada;
    • Migliaccio, Fortuna;
    • Tortora, Giampaolo;
    • Leccisotti, Lucia;
    • Sambuceti, Gianmario;
    • Giordano, Alessandro;
    • Caffo, Orazio;
    • Iacovelli, Roberto
    Publication type:
    Article
    14

    Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Rizzo, Mimma;
    • Galli, Luca;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah
    Publication type:
    Article
    15

    Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

    Published in:
    Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Grande, Enrique;
    • Procopio, Giuseppe;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • De Giorgi, Ugo;
    • Basso, Umberto;
    • Milella, Michele;
    • Iacovelli, Roberto;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Buti, Sebastiano;
    • Caffo, Orazio;
    • Fornarini, Giuseppe;
    • Carrozza, Francesco;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Farag, Fady;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    16

    Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    Correction Notice
    17

    Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23

    Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
    By:
    • Stellato, Marco;
    • Buti, Sebastiano;
    • Maruzzo, Marco;
    • Bersanelli, Melissa;
    • Pierantoni, Francesco;
    • De Giorgi, Ugo;
    • Di Napoli, Marilena;
    • Iacovelli, Roberto;
    • Vitale, Maria Giuseppa;
    • Ermacora, Paola;
    • Malgeri, Andrea;
    • Maiorano, Brigida Anna;
    • Prati, Veronica;
    • Mennitto, Alessia;
    • Cavo, Alessia;
    • Santoni, Matteo;
    • Carella, Claudia;
    • Fratino, Lucia;
    • Procopio, Giuseppe;
    • Verzoni, Elena
    Publication type:
    Article
    24

    The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.

    Published in:
    Pathology & Oncology Research, 2018, v. 24, n. 3, p. 447, doi. 10.1007/s12253-017-0271-x
    By:
    • Massari, Francesco;
    • Ciccarese, Chiara;
    • Hes, Ondrej;
    • Michal, Michal;
    • Caliò, Anna;
    • Fiorentino, Michelangelo;
    • Giunchi, Francesca;
    • D’Amuri, Alessandro;
    • Sanguedolce, Francesca;
    • Sabbatini, Roberto;
    • Guida, Annalisa;
    • Ardizzoni, Andrea;
    • Porta, Camillo;
    • Iacovelli, Roberto;
    • Tortora, Giampaolo;
    • Cima, Luca;
    • Ortega, Cinzia;
    • Lapini, Alberto;
    • Martignoni, Guido;
    • Brunelli, Matteo
    Publication type:
    Article
    25

    Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.

    Published in:
    Urologia Internationalis, 2018, v. 101, n. 1, p. 38, doi. 10.1159/000490622
    By:
    • Porcaro, Antonio Benito;
    • Tafuri, Alessandro;
    • Sebben, Marco;
    • Corsi, Paolo;
    • Pocessali, Tania;
    • Pirozzi, Marco;
    • Amigoni, Nelia;
    • Rizzetto, Riccardo;
    • Mariotto, Arianna;
    • Inverardi, Davide;
    • Brunelli, Matteo;
    • Iacovelli, Roberto;
    • Romano, Mario;
    • Siracusano, Salvatore;
    • Artibani, Walter
    Publication type:
    Article
    26
    27

    DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.

    Published in:
    British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 581, doi. 10.1111/bcp.12631
    By:
    • Falvella, Felicia Stefania;
    • Cheli, Stefania;
    • Martinetti, Antonia;
    • Mazzali, Cristina;
    • Iacovelli, Roberto;
    • Maggi, Claudia;
    • Gariboldi, Manuela;
    • Pierotti, Marco Alessandro;
    • Di Bartolomeo, Maria;
    • Sottotetti, Elisa;
    • Mennitto, Roberta;
    • Bossi, Ilaria;
    • Braud, Filippo;
    • Clementi, Emilio;
    • Pietrantonio, Filippo
    Publication type:
    Article
    28
    29
    30

    Gemcitabine-Induced Extensive Skin Necrosis.

    Published in:
    Case Reports in Medicine, 2012, p. 1, doi. 10.1155/2012/831616
    By:
    • D'epiro, Sara;
    • Salvi, Monica;
    • Mattozzi, Carlo;
    • Giancristoforo, Simona;
    • Campoli, Marco;
    • Zanniello, Ramona;
    • Luci, Cecilia;
    • Macaluso, Laura;
    • Giovannoni, Sara;
    • Iacovelli, Roberto;
    • Calvieri, Stefano;
    • Richetta, Antonio Giovanni
    Publication type:
    Article
    31
    32

    Study design and clinical evidence in mRCC.

    Published in:
    Cancer Biology & Therapy, 2014, v. 15, n. 5, p. 486, doi. 10.4161/cbt.28161
    By:
    • Iacovelli, Roberto;
    • Verzoni, Elena;
    • De Braud, Filippo Maria;
    • Procopio, Giuseppe
    Publication type:
    Article
    33
    34
    35
    36
    37

    Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases.

    Published in:
    International Journal of Biological Markers, 2017, v. 32, n. 2, p. e243, doi. 10.5301/jbm.5000246
    By:
    • Munari, Enrico;
    • Cima, Luca;
    • Massari, Francesco;
    • Bertoldo, Francesco;
    • Porcaro, Antonio Benito;
    • Caliò, Anna;
    • Riva, Giulio;
    • Ciocchetta, Elisa;
    • Ciccarese, Chiara;
    • Modena, Alessandra;
    • Iacovelli, Roberto;
    • Sava, Teodoro;
    • Eccher, Albino;
    • Ghimenton, Claudio;
    • Tortora, Giampaolo;
    • Artibani, Walter;
    • Novella, Giovanni;
    • Bogina, Giuseppe;
    • Zamboni, Giuseppe;
    • Sanguedolce, Francesca
    Publication type:
    Article
    38
    39
    40

    Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.

    Published in:
    BJU International, 2012, v. 110, n. 5, p. 692, doi. 10.1111/j.1464-410X.2012.10946.x
    By:
    • Masini, Cristina;
    • Sabbatini, Roberto;
    • Porta, Camillo;
    • Procopio, Giuseppe;
    • Di Lorenzo, Giuseppe;
    • Onofri, Azzurra;
    • Buti, Sebastiano;
    • Iacovelli, Roberto;
    • Invernizzi, Roberta;
    • Moscetti, Luca;
    • Aste, Maria Giuseppina;
    • Pagano, Maria;
    • Grosso, Federica;
    • Lucia Manenti, Anna;
    • Ortega, Cinzia;
    • Cosmai, Laura;
    • Del Giovane, Cinzia;
    • Conte, Pier Franco
    Publication type:
    Article
    41
    42
    43
    44

    Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer.

    Published in:
    Cancers, 2019, v. 11, n. 1, p. 30, doi. 10.3390/cancers11010030
    By:
    • Dalbeni, Andrea;
    • Ciccarese, Chiara;
    • Bevilacqua, Michele;
    • Benati, Marco;
    • Caimmi, Cristian;
    • Cerrito, Luca;
    • Famà, Federico;
    • Iacovelli, Roberto;
    • Mantovani, Anna;
    • Meneguzzi, Francesco Massari Alessandra;
    • Minuz, Pietro;
    • Montagnana, Martina;
    • Orsolini, Giovanni;
    • Rossini, Maurizio;
    • Tortora, Gianpaolo;
    • Viapiana, Ombretta;
    • Fava, Cristiano
    Publication type:
    Article
    45
    46
    47

    Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.

    Published in:
    2017
    By:
    • Pietrantonio, Filippo;
    • Di Bartolomeo, Maria;
    • Cotsoglou, Christian;
    • Mennitto, Alessia;
    • Berenato, Rosa;
    • Morano, Federica;
    • Coppa, Jorgelina;
    • Perrone, Federica;
    • Iacovelli, Roberto;
    • Milione, Massimo;
    • Alessi, Alessandra;
    • Vaiani, Marta;
    • Bossi, Ilaria;
    • Ricchini, Francesca;
    • Scotti, Mauro;
    • Caporale, Marta;
    • Bajetta, Emilio;
    • de Braud, Filippo;
    • Mazzaferro, Vincenzo
    Publication type:
    journal article
    48

    Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?

    Published in:
    Medicina (1010660X), 2023, v. 59, n. 12, p. 2063, doi. 10.3390/medicina59122063
    By:
    • Russo, Pierluigi;
    • Marino, Filippo;
    • Rossi, Francesco;
    • Bizzarri, Francesco Pio;
    • Ragonese, Mauro;
    • Dibitetto, Francesco;
    • Filomena, Giovanni Battista;
    • Marafon, Denise Pires;
    • Ciccarese, Chiara;
    • Iacovelli, Roberto;
    • Pandolfo, Savio Domenico;
    • Aveta, Achille;
    • Cilio, Simone;
    • Napolitano, Luigi;
    • Foschi, Nazario
    Publication type:
    Article
    49

    Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
    By:
    • Santoni, Matteo;
    • Myint, Zin W.;
    • Büttner, Thomas;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Küronya, Zsófia;
    • Tural, Deniz;
    • Pichler, Renate;
    • Grande, Enrique;
    • Crabb, Simon J.;
    • Kemp, Robert;
    • Massari, Francesco;
    • Scagliarini, Sarah;
    • Iacovelli, Roberto;
    • Vau, Nuno;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    50